There was only one study for each that evaluated the association between HMGA2 expression and OS in pancreatic ductal adenocarcinoma, ampullary adenocarcinoma, breast cancer, ccRCC, intrahepatic cholangiocarcinoma, and hepatocellular carcinoma. Here, HMGA2 is linked to pancreatic ductal adenocarcinoma.